Home Tags Posts tagged with "sputnik v vaccine"

sputnik v vaccine

Image source: Wikimedia Commons

The Russian coronovirus vaccine showed around 92% protection against Covid-19, late stage trial results published in The Lancet reveal.

Sputnik V vaccine has also been deemed to be safe – and offer complete protection against hospitalization and death.

The vaccine was initially met with some controversy after being rolled out before the final trial data had been released.

However, scientists said the Russian vaccine’s benefit has now been demonstrated.

Sputnik V joins the ranks of proven vaccines alongside Pfizer, Oxford/AstraZeneca, Moderna and Janssen.

It works in a similar way to the Oxford/AstraZeneca vaccine developed in the UK, and the Janssen vaccine developed in Belgium.

Sputnik V uses a cold-type virus, engineered to be harmless, as a carrier to deliver a small fragment of the coronavirus to the body.

Safely exposing the body to part of the virus’s genetic code in this way allows it to recognize the threat and learn to fight it off, without risking becoming ill.

After being vaccinated, the body starts to produce antibodies specially tailored to the coronavirus.

This means the immune system is primed to fight coronavirus when if it encounters it for real.

The Russian vaccine can be stored at temperatures of between 2 and 8C degrees (a standard fridge is roughly 3-5C degrees) making it easier to transport and store.

But unlike other similar vaccines, Sputnik V uses two slightly different versions of the vaccine for the first and second dose – given 21 days apart.

They both target the coronavirus’s distinctive “spike”, but use different vectors – the neutralized virus that carries the spike to the body.

The idea is that using two different formulas boosts the immune system even more than using the same version twice – and may give longer-lasting protection.

As well as proving effective, it was also safe with no serious reactions linked to the vaccine during the trial.

Sputnik V: Hungary Gives Preliminary Approval to Russian Coronavirus Vaccine

Coronavirus: AstraZeneca and Sputnik V Vaccines to Be Combined in New Trial

Some side effects to a vaccine are expected but these are usually mild, including a sore arm, tiredness and a bit of a temperature.

There were no deaths or serious illness in the vaccinated group linked to the Russian vaccine.

As well as Russia, Sputnik V is being used in a number of other places, including: Argentina, Venezuela, Hungary, UAE, Iran, Palestinian territories.

The authors of the Lancet paper pointed out the analysis only included symptomatic cases of Covid, and more work would need to be done to understand whether it stops even asymptomatic cases, and prevents the virus from being passed on by vaccinated people.

British and Russian scientists are teaming up to trial a combination of the Oxford-AstraZeneca and Sputnik V vaccines to see if protection against Covid-19 can be improved.

According to the researchers, mixing two similar vaccines could lead to a better immune response in people.

The trials, to be held in Russia, will involve over-18s, although it’s not clear how many people will be involved.

Oxford recently published results showing their vaccine was safe and effective in trials on people.

The researchers are still collecting data on the effectiveness of the vaccine in older age groups while waiting for approval from the UK regulator, the MHRA.

AstraZeneca said it was exploring combinations of different adenovirus vaccines to find out whether mixing them leads to a better immune response and, therefore, greater protection.

The Oxford vaccine, developed in partnership with AstraZeneca, and the Russian Sputnik vaccine, developed by the Gamaleya Research Institute in Moscow, are similar because they both contain genetic material from the Sars-CoV-2 spike protein.

They work differently to the Pfizer-BioNTech vaccine, which has been approved in the UK, Canada, Bahrain, Saudi Arabia and recommended for approval by medical experts in the US.

Joe Biden Sets 100M Covid Vaccinations Goal for First 100 Days

Pfizer Coronavirus Vaccine Approved in UK

Pfizer Vaccine Appears to Protect 94% of Adults over 65 Years Old

Early results from late-stage trials of the Russian vaccine have shown promising results.

Russia was the first country to register a Covid vaccine for emergency use – in August, despite only having been tested on a few dozen people.

Sputnik V is now being offered to Russians as part of a mass vaccination campaign.

AstraZeneca said it was “working with industry partners, governments and research institutions around the world, and will soon begin exploring with Gamaleya Research Institute in Russia to understand whether two adenovirus-based vaccines can be successfully combined”.